Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
27
2
2019
Statut:
ppublish
Résumé
This study was aimed to estimate the survival rate characteristics of 2887 hepatocellular carcinoma (HCC) patients in the single-center and identify useful prognostic factors to help in the clinical management of patients with HCC.Two thousand eight hundred eighty-seven patients diagnosed with HCC at the Fourth Hospital of Hebei Medical University, China, between January 2002 and December 2015 were involved.The causes and baseline characteristics were summarized. Median survival time was 9.0 (20.0) months. Overall, HCC patients showed 1-, 2-, 3-, and 5-year survival rates equal to 49.3%, 35.3%, 26.6%, and19.5% respectively. The median survival time of HCC patients first hospitalized in 2009 to 2015 was higher than those in 2002 to 2008. The results showed that the Barcelona clinic liver cancer (BCLC) stage and Tumor size were independent prognostic factors to HCC patients.The survival rate of HCC patients has increased in recent years, but the overall survival rate and the prognosis were poor.
Identifiants
pubmed: 30681563
doi: 10.1097/MD.0000000000014070
pii: 00005792-201901250-00013
pmc: PMC6358325
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14070Références
Aliment Pharmacol Ther. 2018 Sep;48(6):598-609
pubmed: 30039640
Chin J Cancer Res. 2016 Jun;28(3):286-300
pubmed: 27478314
Gut. 2003 May;52 Suppl 3:iii1-8
pubmed: 12692148
JAMA. 2012 Nov 14;308(18):1906-14
pubmed: 23162861
J Hepatocell Carcinoma. 2015 Jan 30;2:3-9
pubmed: 27508189
Biomed Pharmacother. 2016 Dec;84:1679-1688
pubmed: 27823920
J Cancer Res Clin Oncol. 1998;124(7):397-400
pubmed: 9719503
J Clin Cell Immunol. 2015 Dec;6(6):
pubmed: 26877890
Contemp Oncol (Pozn). 2018;22(3):141-150
pubmed: 30455585
Cancer. 2004 Jun 1;100(11):2415-21
pubmed: 15160346
J Gastroenterol. 2009;44(9):991-9
pubmed: 19554391
Korean J Hepatol. 2012 Mar;18(1):48-55
pubmed: 22511903
Liver Cancer. 2018 Sep;7(3):235-260
pubmed: 30319983
J Gastroenterol Hepatol. 2002 Jan;17(1):52-8
pubmed: 11895553
Cancer. 2010 Aug 1;116(15):3638-44
pubmed: 20564097
J Egypt Natl Canc Inst. 2013 Sep;25(3):143-50
pubmed: 23932751